PATENT CLAIM ANALYSIS

Application Number: 16272934
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-08
Patent Classification: ["544", "281000"]

Abstract:
The invention concerns novel substituted pyrazolo- and triazolo-pyrimidine compounds of formula (I) having antiviral activity, in particular, having an inhibitory activity on the replication of the respiratory syncytial virus (RSV). The invention further concerns pharmaceutical compositions comprising these compounds and the compounds for use in the treatment of respiratory syncytial virus infection.

Claim (Index 5):
The compound as claimed in  claim 3  wherein the moiety is a radical of formula (a-1) to (a-15) wherein R 1  is CH 3  or CH 2 CH 3 , and R 1\u2032  is hydrogen; or R 1\u2032  is absent in radical (a-6); or R 1  and R 1\u2032  are taken together with the carbon atom to which they are attached to form cyclopropyl; and radical (a-1) to (a-15) are optionally substituted with one or two substituents each independently selected from C 1-2 alkyl and halo.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 99.0
- Lexical Diversity: 1.53846
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15570054', '15534442', '12293545', '11569108', '12988891']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7765288201224572
- 35 USC 102 Novelty (BERT): 0.56900213899567
- Combined Prediction Score: 0.7557761520097784
- Mean Citation Score: 300.244926
- Max Citation Score: 431.0718
- Similarity Product: 424.1152329684734

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test